Incidence of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency Undergoing Multidetector Computed Tomographic Angiography Treated With Preventive Measures

American Journal of Cardiology

Volumn 102, Issue 3, 2008, Pages 353-356

  El Hajjar, Mohammad ^a   Bashir, Iqbal ^a   Khan, Muhammad ^a   Min, James ^b   Torosoff, Mikhail ^a   DeLago, Augustin ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CREATININE; IODIXANOL;

AGED; ARTERY DISEASE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFIDENCE INTERVAL; CONTRAST MEDIUM INDUCED NEPHROPATHY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG INDUCED DISEASE; FEMALE; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; OUTPATIENT; PREDICTIVE VALIDITY; PREDICTOR VARIABLE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK;

ACETYLCYSTEINE; AGED; ANGIOGRAPHY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; SODIUM BICARBONATE; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

EID: 51749099381     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.067     Document Type: Article

References (26)

1. Detrenis S., Meschi M., Musini S., and Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Tranplant 20 (2005) 1542-1550
2. Tepel M., Van Der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
3. Pannu N., Manns B., Lee H., and Tonelli M. Systematic review of the impact of N-acetylecysteine on contrast nephropathy. Kidney Int 65 (2004) 1366-1374
4. Bagshaw S.M., and Ghali W.A. Acetylcysteine for the prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis. [abstract]. BMC Med 2 (2004) 38
5. Liu R., Nair D., Ix J., Moore D.H., and Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. J Gen Intern Med 20 (2005) 193-200
6. Duong M.H., MacKenzie T.A., and Malenka D.J. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv 64 (2005) 471-479
7. Nallamothu B.K., Shojania K.G., Saint S., Hofer T.P., Humes H.D., Moscucci M., and Bates E.R. Is acetylcysteine effective in preventing contrast-related nephropathy?. A meta-analysis. Am J Med 117 (2004) 938-947
8. Birck R., Krzossok S., Markowetz F., Schnulle P., Van Der Woude F.J., and Braun C. Acetylcysteine for the prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
9. Isenbarger D.W., Kent S.M., and O'Malley P.G. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 92 (2003) 1454-1458
10. Alonso A., Lau J., Jaber B.L., Weintraub A., and Samak M.J. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 43 (2004) 1-9
11. Misra D., Leibowitz K., Gowda R.M., Shapiro M., and Khan I.A. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis. Clin Cardiol 2 (2004) 607-610
12. Kshirsagar A.V., Poole C., Mottl A., Shoham D., Franceschini N., Tudor G., Agarwal M., Denu-Ciocca C., Magnus Ohman E., and Finn W.F. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15 (2004) 761-769
13. Guru V., and Fremes S.E. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy. Clin Nephrol 62 (2004) 77-83
14. Merten G.J., Burgess W.P., Gray L.V., Holleman J.H., Roush T.S., Kowalchuk G.J., Bersin R.M., Van Moore A., Simonton C.A., Rittase R.A., Norton H.J., and Kennedy T.P. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
15. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
16. Recio-Mayoral A., Chaparro M., Prado B., Cozar R., Mendez I., Banerjee D., Kaski J.C., Cubero J., and Cruz J.M. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 49 (2007) 1283-1288
17. Briguori C., Airoldi F., D'Andrea D., Bonizzoni E., Morici N., Focaccio A., Michev I., Montorfano M., Carlino M., Cosgrave J., Ricciardelli B., and Colombo A. Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115 (2007) 1211-1217
18. Tumlin J.A., Wang A., Murray P.T., and Mathur V.S. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J 143 (2002) 894-903
19. Stone G.W., McCullough P.A., Tumlin J.A., Lepor N.E., Madyoon H., Murray P., Wang A., Chu A.A., Schaer G.L., Stevens M., Wilensky R.L., and O'Neill W.W. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290 (2003) 2284-2291
20. Klarenbach S.W., Pannu N., Tonelli M.A., and Manns B.J. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Crit Care Med 34 (2006) 1044-1051
21. Sketch M.H., Whelton A., Schollmayer E., Koch J.A., Bernik P.J.L.M., Woltering F., Brinker J., and Prostaglandin E1 Study Group. Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study. Am J Ther 8 (2001) 155-162
22. Barrett B.J. Contrast nephrotoxicity. J Am Soc Nephrol 5 (1994) 125-137
23. Parfrey P.S., Griffiths S.M., Barrett B.J., Paul M.D., Genge M., Withers J., Farid N., and McManamon P.J. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 320 (1989) 143-149
24. Albert S.G., Shapiro M.J., Brown W.W., Goodgold H., Zuckerman D., Durham R., Kern M., Fletcher J., Wolverson M., and Plummer E.S. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance. Invest Radiol 29 (1994) 618-623
25. Barrett B.J., and Carlisle E.J. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
26. Rich M.W., and Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med 150 (1990) 1237-1242